Bill
HB 6355
Overview: HB 6355, AN ACT REQUIRING HEALTH INSURANCE COVERAGE FOR BIOMARKER TESTING, was referred to the Joint Committee on Insurance and Real Estate. It was introduced on January
Overview: HB 6355, AN ACT REQUIRING HEALTH INSURANCE COVERAGE FOR BIOMARKER TESTING, was referred to the Joint Committee on Insurance and Real Estate. It was introduced on January 23, 2025.
Purpose and Intent: The main goal of this bill is to mandate that health insurance plans in the state cover biomarker testing for certain medical conditions.
Key Provisions:
- Requires all health insurance policies to provide coverage for biomarker testing when:
- Recommended by a healthcare provider for diagnosis, treatment, or monitoring of a medical condition
- The test is approved by the FDA or recommended by national professional medical associations
- Prohibits insurers from imposing cost-sharing requirements or other limitations on biomarker testing coverage
Affected Parties and Impacts:
- Patients will have improved access to biomarker testing, which can inform personalized medical treatment
- Health insurance providers will be required to cover these tests without cost-sharing
Procedural and Timeline Considerations:
The bill has been referred to the Joint Committee on Insurance and Real Estate and is awaiting further legislative action.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
